Literature DB >> 19325055

MR imaging of hypervascular liver masses: a review of current techniques.

Alvin C Silva1, James M Evans, Ann E McCullough, Mashal A Jatoi, Hugo E Vargas, Amy K Hara.   

Abstract

Major technologic advances in magnetic resonance (MR) imaging, including the advent of novel pulse sequences (eg, diffusion-weighted and steady-state free precession sequences) and the use of hepatocyte-specific contrast agents, have led to better image quality and shorter acquisition times, resulting in dramatic improvements in the noninvasive detection and characterization of hepatic lesions, particularly hypervascular neoplasms. However, as the role of MR imaging in clinical evaluation of the liver continues to evolve, keeping abreast of new developments can be daunting as well as confusing. A systematic approach that makes use of a simple decision algorithm can help differentiate hypervascular hepatic lesions on the basis of their distinguishing MR imaging characteristics and related clinical information. (c) RSNA, 2009.

Entities:  

Mesh:

Year:  2009        PMID: 19325055     DOI: 10.1148/rg.292085123

Source DB:  PubMed          Journal:  Radiographics        ISSN: 0271-5333            Impact factor:   5.333


  21 in total

1.  Magnetic resonance imaging: Review of imaging techniques and overview of liver imaging.

Authors:  Santhi Maniam; Janio Szklaruk
Journal:  World J Radiol       Date:  2010-08-28

2.  Gadoxetic acid enhanced MRI for differentiation of FNH and HCA: a single centre experience.

Authors:  Christian Grieser; Ingo G Steffen; Incken-Birthe Kramme; Hendrik Bläker; Ergin Kilic; Carmen Maria Perez Fernandez; Daniel Seehofer; Eckart Schott; Bernd Hamm; Timm Denecke
Journal:  Eur Radiol       Date:  2014-06       Impact factor: 5.315

3.  Quantitative multiparametric PROPELLER MRI of diethylnitrosamine-induced hepatocarcinogenesis in wister rat model.

Authors:  Jie Deng; Ning Jin; Xiaoming Yin; Guang-Yu Yang; Zhuoli Zhang; Reed A Omary; Andrew C Larson
Journal:  J Magn Reson Imaging       Date:  2010-05       Impact factor: 4.813

4.  Liver segmentation and metastases detection in MR images using convolutional neural networks.

Authors:  Mariëlle J A Jansen; Hugo J Kuijf; Maarten Niekel; Wouter B Veldhuis; Frank J Wessels; Max A Viergever; Josien P W Pluim
Journal:  J Med Imaging (Bellingham)       Date:  2019-10-15

Review 5.  [Benign focal hepatic lesions].

Authors:  S Baroud; N Bastati; H Prosch; W Schima; A Ba-Ssalamah
Journal:  Radiologe       Date:  2011-08       Impact factor: 0.635

6.  Chronic active hepatitis induced by Pazopanib mimicking hypervascular liver metastases in a patient with recurrent soft tissue sarcoma: A case report.

Authors:  Ana Ezponda; Ignacio González De La Huebra; Marta Calvo; Miguel Ángel Idoate; Isabel Vivas
Journal:  Oncol Lett       Date:  2018-07-10       Impact factor: 2.967

7.  Non-Hypervascular Hypointense Nodules at Gadoxetic Acid MRI: Hepatocellular Carcinoma Risk Assessment with Emphasis on the Role of Diffusion-Weighted Imaging.

Authors:  Chiara Briani; Marco Di Pietropaolo; Massimo Marignani; Francesco Carbonetti; Paola Begini; Vincenzo David; Elsa Iannicelli
Journal:  J Gastrointest Cancer       Date:  2018-09

Review 8.  Early detection of intrahepatic cholangiocarcinoma.

Authors:  Mami Hamaoka; Kazuto Kozaka; Osamu Matsui; Takahiro Komori; Takashi Matsubara; Norihide Yoneda; Kotaro Yoshida; Dai Inoue; Azusa Kitao; Wataru Koda; Toshifumi Gabata; Satoshi Kobayashi
Journal:  Jpn J Radiol       Date:  2019-08-01       Impact factor: 2.374

9.  Clinical Translation of an Albumin-Binding PET Radiotracer 68Ga-NEB.

Authors:  Jingjing Zhang; Lixin Lang; Zhaohui Zhu; Fang Li; Gang Niu; Xiaoyuan Chen
Journal:  J Nucl Med       Date:  2015-08-06       Impact factor: 10.057

10.  SSAT/AHPBA joint symposium on evaluation and treatment of benign liver lesions.

Authors:  Yun Shin Chun; Michael G House; Harmeet Kaur; Evelyne M Loyer; Valérie Paradis; Jean-Nicolas Vauthey
Journal:  J Gastrointest Surg       Date:  2013-02-02       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.